Coridea
1 known investors
Find your way into Coridea
123 people in our graph share verified history with the Coridea team — schools, employers, funds. One of them is your warm intro.
Jared Winegradunlockedknows Adam Rosenwach · together at Berklee College of Music (overlapped)
×6knows the team · via Berklee College of Music
×3knows the team · via Icahn School of Medicine at Mount Sinai
×2knows the team · via Johns Hopkins School of Medicine
Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.
Founders & leadership
MG
Mark GelfandinManaging Partner and Chief Technical OfficerMark Gelfand has over 25 years of experience in medical device development across academic, startup, and corporate settings, with expertise in integrative physiology, systems engineering, and intellectual property. He co-founded multiple healthcare companies including Axon Therapies, Soffio Medical, Cibiem, CHF Solutions, Ardian, and Respicardia, served as CTO at several medical device firms including CardioLogic Systems and Nellcor Puritan Bennett, and holds a master's degree in electrical engineering from St. Petersburg Institute of Technology and graduate-level physiology training from Johns Hopkins School of Medicine.
HR
Howard R. LevininManaging Partner, President, and Chief Medical OfficerHoward Levin is a cardiologist trained in heart failure and transplantation who now serves as managing partner, president, and chief medical officer of Coridea, a healthcare investment firm developing patient-centric medical technology ventures.
ZE
Zoar EngelmaninPartner and Chief Scientific Officer
AR
Investors · 1
Founder mafia
3 people who came through Coridea went on to found or lead other companies.
Non-dilutive funding · 13 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $907.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $278.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $246.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $997.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Coridea do?
- Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.
- Who founded Coridea?
- Coridea was founded by Mark Gelfand, Howard R. Levin.
- Who are Coridea's investors?
- Coridea's investors include Broadview Ventures.